Glysantis Inc. is located in Guelph, Canada on 574 Hanlon Creek Boulevard. Glysantis Inc. is rated 3 out of 5 in the category company in Canada. Glysantis Inc is a pre-clinical stage company involved in the research and development of therapeutics based on a proprietary nanoparticle technology platform called NanoDendrix. Key areas of focus are immunomodulation and targeted drug delivery.
Address
574 Hanlon Creek Boulevard
Company size
1-10 employees
Headquarters
Guelph, Ontario